A study of Medicare patients with osteoarthritis provides additional evidence that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin reduce the risk of colorectal cancer.
Millions of Americans take statins to lower their cholesterol, but how low should you go” Many scientific studies support the benefits of lowering low-density lipoprotein (LDL) cholesterol, and achieving low LDL cholesterol levels is one of the most important steps in preventing heart disease.
Overcoming pediatric cancer may only mark the beginning of a young survivor?s lifelong battle to stay healthy. While survivors of childhood acute lymphoblastic leukemia (ALL) face an increased risk of developing serious health complications as a result of their cancer treatment, for a variety of reasons many avoid simple exercise and healthy lifestyle changes that could reverse the damage, according to a team of researchers based at Memorial Sloan-Kettering Cancer Center.
Two new studies emphasize the importance of delivering measles and influenza vaccines to HIV-infected individuals. Both studies are published in the August 1 issue of The Journal of Infectious Diseases, now available online.
Older women who get yearly mammograms after treatment of early-stage breast cancer are less likely to die from breast cancer, according to a study in the July 20, 2007 issue of the Journal of Clinical Oncology.
One route to a long and healthy life may be establishing the right balance in insulin signaling between the brain and the rest of the body, according to new research from Children’s Hospital Boston.
Newer drug therapies available since the 1990s, in particular aromatase inhibitors, improve the survival of women with metastatic breast cancer in the general population, according to a new study.
A follow up to a previous study on group therapy in breast cancer patients finds group therapy does not prolong the lives of women with metastatic breast cancer.
Growth hormone injections appear to boost height in extremely short, healthy children, according to a recent systematic review, but height gain appears to peak at about three inches ? and those inches are expensive.
The Paul Milstein family has donated $5.5 million to create the Milstein Medical Research Program at Rockefeller University. The initial research efforts will be in the area of skin cancer and will be led by Dr. James G. Krueger, D. Martin Carter Professor and head of the Laboratory for Investigative Dermatology at Rockefeller.